HOLOGRAPHIC GENOME SEQUENCING - Trademark Details
Status: 601 - Abandoned - Express
Serial Number
90002945
Word Mark
HOLOGRAPHIC GENOME SEQUENCING
Status
601 - Abandoned - Express
Status Date
2021-04-26
Filing Date
2020-06-15
Mark Drawing
4000 - Standard character mark
Typeset
Law Office Assigned Location Code
L50
Employee Name
PEISECKI, MARK A
Statements
In Another Form Statement
The mark was first used anywhere in a different form other than that sought to be registered at least as early as 10/20/2006
In Another Form Statement
The mark was first used in commerce in a different form other than that sought to be registered at least as early as 09/08/2007
Goods and Services
DNA analysis services for scientific research purposes; DNA analysis services to determine paternity; DNA screening for scientific research purposes; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Genome amplification; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Drug, alcohol and DNA screening for forensic research purposes; Providing information in the field of plant genetics research resources; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing scientific research information in the field of genetics; Providing scientific research information in the field of genomics; Providing scientific research information in the field of holographic genome sequencing; Providing scientific research information in the field of holographic genome testing; Providing scientific research information in the field of gene splicing; Providing scientific research information in the field of holographic gene splicing; Providing scientific research information in the field of decoding genes; Providing scientific research information in the field of decoding genomes; Providing scientific research information in the field of decoding DNA; Providing scientific research information in the field of holographic genome decoding; Providing scientific research information in the field of holographic genomic decoding; Providing scientific research information in the field of genome decoding holography; Scientific research consulting in the field of genetics; Scientific research consulting in the field of genomics; Scientific research consulting in the field of holographic genome sequencing; Scientific research consulting in the field of holographic genome testing; Scientific research consulting in the field of gene splicing; Scientific research consulting in the field of holographic gene splicing; Scientific research consulting in the field of decoding genes; Scientific research consulting in the field of decoding genomes; Scientific research consulting in the field of decoding DNA; Scientific research consulting in the field of holographic genome decoding; Scientific research consulting in the field of holographic genomic decoding; Scientific research consulting in the field of genome decoding holography; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of genetics; Scientific research in the field of genomics; Scientific research in the field of holographic genome sequencing; Scientific research in the field of holographic genome testing; Scientific research in the field of gene splicing; Scientific research in the field of holographic gene splicing; Scientific research in the field of decoding genes; Scientific research in the field of decoding genomes; Scientific research in the field of decoding DNA; Scientific research in the field of holographic genome decoding; Scientific research in the field of holographic genomic decoding; Scientific research in the field of genome decoding holography; Structural and functional analysis of genomes; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-07-13
Primary Code
042
Correspondences
Name
Carl Raymond Amos
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-06-18 | NEW APPLICATION ENTERED IN TRAM |
2020-07-13 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-09-16 | ASSIGNED TO EXAMINER |
2020-09-22 | NON-FINAL ACTION WRITTEN |
2020-09-22 | NON-FINAL ACTION E-MAILED |
2020-09-22 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-03-22 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-03-22 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-03-22 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-04-26 | ABANDONMENT - EXPRESS MAILED |
2021-04-26 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |